Sponsor:
Orlando Health, Inc.
Code:
NCT07696572
Conditions
Pancreatic Fluid Collections
Biliary Obstruction
Pancreatic Duct Obstruction
Chronic Pancreatitis
Pancreatic Cancer Non-resectable
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
EUS-guided intervention using the RIVOS™ EUS access device
Brief summary:
Conditions
Pancreatic Fluid Collections
Biliary Obstruction
Pancreatic Duct Obstruction
Chronic Pancreatitis
Pancreatic Cancer Non-resectable
Study ID
NCT07696572
Start date
Jul, 2026
Status verified date
Jul, 2026
Completion date
Dec, 2027
Anticipated
Primary completion date
Jul, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
30 participants
Anticipated
Arms
Patients requiring interventional EUS procedures
Interventions
EUS-guided intervention using the RIVOS™ EUS access device
Primary outcome measure
Central contacts
Locations
Orlando Health Digestive Health Institute
Recruiting
Orlando, Florida, United States, 32806
Contacts
Barbara J Broome
barbara.broome@orlandohealth.comPrincipal Investigator:
Ji Young Bang, MD MPH
Sponsor
Orlando Health, Inc.
Last update posted
Jul 10, 2026
Last verified
Jul, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Orlando Health, Inc. on 2026-07-10.